Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6733182 | 7351170 | F | 6733182-7 | 20100301 | 20100514 | 20100520 | PER | US-BIOGENIDEC-2010BI011238 | BIOGEN IDEC INC. | 55 | YR | F | Y | 20100520 | OT | UNITED STATES |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
6733182 | 1013718664 | PS | TYSABRI | 1 | INTRAVENOUS |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
6733182 | 1013718664 | MULTIPLE SCLEROSIS |
Outcome of event
Event ID | OUTC COD |
---|---|
6733182 | HO |
Reactions reported
Event ID | PT |
---|---|
6733182 | APHASIA |
6733182 | COMMUNICATION DISORDER |
6733182 | CONFUSIONAL STATE |
6733182 | DEPRESSION |
6733182 | DISORIENTATION |
6733182 | MULTIPLE SCLEROSIS RELAPSE |
6733182 | SPEECH DISORDER |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
6733182 | 1013718664 | 20100304 |